4.5 Pediatrics Only few small studies have assessed the use of GLP-1RA as adjuvant therapy in pediatric patients with T1D
Now that injectable GHK-Cu is legally available, some providers may suggest it for hair loss protocols
The water you draw carries whatever accumulated risk its parent vial holds at that moment
After switching from alogliptin 25 mg daily to dulaglutide 0.75 mg weekly, and reducing IDeg/Asp from 36 to 24 units/day while maintaining other antidiabetic drugs, glycemic control was effectively maintained during the subsequent hospitalization
Cyanocobalamin injection may contain aluminum, which may be toxic to the kidneys, especially to infants
Retatrutide is investigated as a triple receptor agonist , interacting with GLP-1 receptors, GIP receptors, and glucagon receptors